GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Price-to-Operating-Cash-Flow

Laboratorio Reig Jofre (XMAD:RJF) Price-to-Operating-Cash-Flow : (As of Apr. 29, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre Price-to-Operating-Cash-Flow?

As of today (2024-04-29), Laboratorio Reig Jofre's share price is €2.58. Laboratorio Reig Jofre's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00. Hence, Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow or its related term are showing as below:

XMAD:RJF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 19.15
Current: 10.62

During the past 13 years, Laboratorio Reig Jofre's highest Price-to-Operating-Cash-Flow Ratio was 19.15. The lowest was 0.00. And the median was 0.00.

XMAD:RJF's Price-to-Operating-Cash-Flow is ranked better than
71.01% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.435 vs XMAD:RJF: 10.62

Laboratorio Reig Jofre's Cash Flow from Operations per share for the three months ended in Dec. 2023 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Laboratorio Reig Jofre was 18.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 2.40% per year.

During the past 13 years, Laboratorio Reig Jofre's highest 3-Year average Operating Cash Flow per Share Growth Rate was 152.00% per year. The lowest was -8.70% per year. And the median was 7.70% per year.


Laboratorio Reig Jofre Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Price-to-Operating-Cash-Flow Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.37 18.22 17.63 10.68 9.26

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.68 - - 9.26

Competitive Comparison of Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow falls into.



Laboratorio Reig Jofre Price-to-Operating-Cash-Flow Calculation

Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=2.58/0
=

Laboratorio Reig Jofre's Share Price of today is €2.58.
Laboratorio Reig Jofre's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Laboratorio Reig Jofre Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (XMAD:RJF) Business Description

Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.